Bangladesh Medical College’s Dr. Tarek Alam’s Ivermectin Working 98% With Between 400-500 Patients & More Research to Come

Jul 20, 2020 | Bangladesh Medical College, Coronavirus, COVID-19, Ivermectin, News, Popular Posts, Tarek Alam

Bangladesh Medical College’s Dr. Tarek Alam’s Ivermectin Working 98% with Between 400-500 Patients & More Research to Come

Dr. Tarek Alam, a highly respected physician and professor of Medicine at Bangladesh Medical College (BMC), used two economical and easily available drugs to treat patients suffering from COVID-19 with considerable success in not only reducing the patients’ viral load, but also cutting the severity of their cases. Dr. Alam, who kindly did an interview with TrialSite News, reports that 98% of his COVID-19 patients are cured by the combined use of anti-parasitic drug ivermectin and antibiotic Doxycycline within 4 to 14 days. As Dr. Alam reported to the TrialSite, he secured BMC approved protocol to use this combination to great success.

Treat Early: Prevent Disease Progression

Dr. Alam was recently highlighted by United News of Bangladesh (UNB) as his study back on April 15 led to tremendous success. Dr. Alam told UNB via a virtual interview, “What we’ve found is that it’s better to use the two drugs as soon as possible after a person is tested positive or symptom is seen.”

Dr. Alam continued, “We use the drugs within 5-6 days on all patients (and almost all got cured). Actually it needs to conduct further study whether these drugs will be effective in case of use over time.” Thus far, he has used the combination of ivermectin and Doxycycline on “some 400-500 COVID patients since April.”

A handful of patients with comorbidities ended up at the Intensive Care Unit, and two patients died despite treatments with both Remdesivir and plasma therapy. It should be noted here that, to date, Remdesivir is not associated with reducing the death rate of SARS-CoV-2.

ICDDR Clinical Trial

As Dr. Alam told the TrialSite, he was an absolute advocate of the randomized controlled study which is now occurring, as he said it would, with Bangladesh’s ICDDR, B. As TrialSite reported, the institute has leveraged Dr. Alam’s successful protocol to study the efficacy and safety of ivermectin and Doxycycline in combination in patients with the COVID-19 infection. This clinical trial should conclude within a month. 

In the meantime, Dr. Alam also pursues more research to demonstrate that this protocol can work to an overwhelmingly dismissed medical and scientific community.

Summary

In the UNB article, the authors take the reader through the origin of ivermectin, the Monash University lab research breakthrough, and highlight Dr. Alam’s caution that for more complex cases, whether elderly patients or those with comorbidities, that hospitalization and other medicines are in order. Dr. Alam also reminds that none of the medicine should be taken arbitrarily and without a prescribing physician. Based on the TrialSite’s interview results, it is very clear that Dr. Alam wants more research done. Despite such a high success rate with hundreds of patients, there is still not enough known about SARS-CoV-2 or why certain treatments might work, at least in certain cases some of the time, until there is substantially more evidence. Ivermectin isn’t a cure, nor can it be declared a proven treatment at this point. But it can be declared that in hospitals and medical facilities around the world, from Bangladesh and India to Peru and Mexico and the Dominican Republic, that there is accumulating localized data pointing toward real promise. And in the middle of a pandemic where lives are at stake, prominent medical institutions in many of these nations have opted to use the drug off-label. Thus far, the reports coming out are overall positive. 

Source: UNB

12 Comments

  1. Ram Bahadur

    What a joke?
    Trial trial and only trial.
    When it will be available and proved his effectiveness?

    • Dr.sunitha pakalapary

      How much is the dosage of ivermectol in this study

      • Tm Erday

        It’s quite a bit: Ivermectin 200µgm/kg of body weight as a single dose + Doxycycline 100mg for 10 days.

  2. Paul

    Is there anyone know if generic ivermectin is all the same wherever is the medicine produced, China or India?

    • Ram Bahadur

      I think in America.

    • Mvg

      Its freely available in India. See netmeds.com getting online consultation and later medicines. 1mg.com also offers similar service.

      • Jason Milner

        I am so disappointed by the entire united states medical/political establishment. This works and could save lives but it’s an election year so no one is looking at this

  3. DR VIVEK GARG

    Yes this combination is very effective. I have used in 25 odd patients(Covid positive) of mine who were symptomatic and none of the patients got hospitalised.
    Rather treatment was on online mode.

  4. Hein De Waele

    Can Ivermectin be taken as a preventive and how effective is it in that role?

  5. Pankaj Bohra

    I have given Ivermectin and Doxy along with Zinc ,Vitamin C to few of my patients. I got good results.

    In fact one patient regained taste and smell in 48-72 hours.

  6. Dave S.

    Here in the USA, the FDA needs to immediately review their EUA (Emergency Use Authorization) protocol to better support potential treatments during pandemics. The FDA should quickly and efficiently:

    1.) Review the various anecdotal success data of these various treatments (i.e. Ivermectin, Doxy, ARB’s, Ciclesonide, Dexa, Heparin, etc.) that appear to be very promising…

    2.) Then review the suspected/hypothesized or proven MOA’s (mechansims of action) to identify and document the believed potential interaction with Covid 19 (SARS-COV-2), in the case of this Pandemic.

    3.) Review the safety profile and safety record of the proposed treatments. As well as various typical dosages for both labeled and off-labled use. Document any potential serious side effects and known drug/condition interactions for informational purposes.

    Then issue the EUA within days or weeks, not months or never. The FDA can always remove the EUA like it did with Hydroxy if subsequent Trials data or further anecdotal data to the contrary out ways the potential benefit/risk of said treatment.

    This lack of action by the FDA is an absolute travesty. I don’t want to speculate too specifically on the “reasons” why the FDA is not issuing more EUA’s, but suffice it say, it’s either incompetence, too much bureaucracy, or adverse motivations. Or a combination of all three. Either way, the people of the USA and the world need better out of the U.S. FDA. The FDA needs to issue EUA’s in order for Physicians in the USA and around the world to have some guidance and “approval” to freely treat Covid 19 patients.

  7. James Fisher

    Fauci gets money from Gilead Phara. So as he pushes resdemivir you have to wonder why such emphasis on a drug with little to no impact on the death rate, and at only $4-5,000 dollars for a course of treatment? Chris Martinson on his corona virus update had a chart showing the death rate for countries that use hydroxychloroquine and resdemivir, and the low death rates were in countries that use hydroxychloroquine!

Pin It on Pinterest